Eur J Musculoskel Dis 2023 Sep-Dec;12(3):165-168
LETTER TO THE EDITOR
OSTEONECROSIS OF THE MANDIBLE ASSOCIATED WITH ZOLEDRONATE THERAPY
F. Fiori1 and A. Romano2
1Independent Researcher, Portici Napoli, Italy;
2Independent Researcher, Marano di Napoli, Italy
Correspondence to:
Antonio Romano, DDS
Multidisciplinary Department of Medical-Surgical and Dental Specialties,
University of Campania Luigi Vanvitelli,
Naples, Italy
e-mail: doctorantonioromano@gmail.com
Received: 19 July 2023 Accepted: 12 September 2023 |
2038-4106(2023) Copyright © by BIOLIFE This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties. Disclosure: all authors report no conflicts of interest relevant to this article. |
KEYWORDS: zoledronate therapy, bone, bisphosphonates, bisphosphonate-related osteoradionecrosis, jaw, BRONJ
